Related Experiment Video
Updated: Jul 10, 2026
14:14
Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
Circulating tumour cell detection on its way to routine diagnostic implementation?
Stefan Sleijfer1, Jan-Willem Gratama, Anieta M Sieuwerts
1Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Clinic, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. s.sleijfer@erasmusmc.nl
European Journal of Cancer (Oxford, England : 1990)
|November 6, 2007
Summary
New assays for circulating tumor cells (CTCs) show promise. Detecting and counting CTCs may help estimate tumor aggressiveness, predict prognosis, and monitor treatment effectiveness.
Area of Science:
- Oncology
- Biomarkers
- Cancer Diagnostics
Background:
- Circulating tumor cells (CTCs) have long been recognized as indicators of tumor aggressiveness.
- Reliable detection and enumeration of CTCs have been challenging, but recent assay advancements are changing this landscape.
Purpose of the Study:
- To review the technical aspects of CTC detection and enumeration assays.
- To discuss the clinical implications of CTC detection, including prognostic and predictive value.
- To explore future perspectives and applications of CTC characterization.
Main Methods:
- Review of current technologies for detecting and enumerating circulating tumor cells.
- Analysis of emerging clinical data from CTC assays in various tumor types.
- Discussion of technical challenges and advancements in CTC characterization.
Main Results:
- Recent CTC assays are now available and showing clinical utility.
- CTC detection and enumeration show potential for estimating prognosis in certain cancers.
- CTCs may serve as early indicators of anti-tumor treatment response.
Conclusions:
- Circulating tumor cell detection and enumeration are becoming valuable tools in oncology.
- Further technical advancements in CTC characterization will enhance prognostic and predictive capabilities.
- CTCs offer insights into tumor biology, including metastasis, drug resistance, and treatment effects.
